Subveho, LLC provides Venture Capitalists, angel investors, academic-affiliated institutions, and other early stage pharmaceutical investors an experienced and innovative team to drive focused, efficient translational development of pharmaceutical assets. We offer pre-investment diligence to investors to ensure business strategy is aligned with operational feasibility. Post-investment, we provide the management team to drive the asset through value inflection points, broaden the network of potential partners and investors, and progress the program to its business and scientific goals.
By de-centralizing the management team from individual assets, Subveho is able to progress early stage pharmaceutical programs efficiently, in a cost effective manner, while still retaining the benefits of an established company. Subveho provides a team of experts, experienced in working together in the start-up space, whose incentives are aligned with the Investors and founders.